About Brattea
Brattea is a company based in Xuhui (China) founded in 2013 by Hongguang Cao. Brattea has raised $15.2 million across 3 funding rounds from investors including Zhongping Capital, Shanghai Healthcare Capital and Shenzhen Dingxin Capital Management. Brattea operates in a competitive market with competitors including ReCor Medical, Ablative Solutions, Autonomix, Kalos Medical and Maya Medical, among others.
- Headquarter Xuhui, China
- Founders Hongguang Cao
-
Sectors
Healthcare
-
Phone
Locked
-
Website
Locked
-
Annual Revenue
Not available
-
Net Profit
Not available
-
EBITDA
Not available
-
Total Equity Funding
$15.2 M (USD)
in 3 rounds
-
Latest Funding Round
Not available
-
Investors
Zhongping Capital
& 8 more
-
Employee Count
Not available
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Funding Insights of Brattea
Brattea has successfully raised a total of $15.2M across 3 strategic funding rounds. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
Investors in Brattea
Brattea has secured backing from 9 investors, including venture fund and institutional investors. Prominent investors backing the company include Zhongping Capital, Shanghai Healthcare Capital and Shenzhen Dingxin Capital Management.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
-
|
Locked | Locked | Locked | |
|
-
|
Locked | Locked | Locked | |
|
Venture capital firm investing in series A startups
|
Locked | Locked | Locked |
Investor details for Brattea
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Brattea
Investment portfolio details for Brattea
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - Brattea
Detailed financials for Brattea
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Brattea Comparisons
Peer comparison for Brattea
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Brattea
Brattea operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as ReCor Medical, Ablative Solutions, Autonomix, Kalos Medical and Maya Medical, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Ultrasound-based renal denervation is applied for hypertension treatment.
|
|
| Locked | Locked | Locked |
A catheter-based renal denervation system for hypertension treatment is developed.
|
|
| Locked | Locked | Locked |
Minimally invasive neural monitoring and treatment devices are developed.
|
|
| Locked | Locked | Locked |
Developer of medical devices for the treatment of hypertension & other chronic diseases
|
|
| Locked | Locked | Locked |
Catheter based ablative technology for renal denervation to treat hypertension
|
Detailed competitors of Brattea
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Brattea
Complete news archive for Brattea
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Brattea
Brattea was founded in 2013 and raised its 1st funding round 8 years after it was founded.
Brattea is headquartered in Xuhui, China. It is registered at Xuhui, Shanghai, China.
Brattea is a funded company, having raised a total of $15.2M across 3 funding rounds to date.
Developer of a medical device for the treatment of hypertension. The product is a Renal artery radiofrequency ablation instrument, a minimally invasive way to deliver the catheter into the renal artery, that performs radiofrequency ablation of the renal artery sympathetic nerve and blocks the sympathetic nerve to treat hypertension and chronic kidney disease hypertension. This device has a mesh basket structure and 6 electrodes. The company also works in the field of tumor analgesia, diabetes, vasculitis, and heart disease.
Brattea's top competitors include ReCor Medical, Autonomix and Ablative Solutions.
Brattea has 9 investors. Key investors include Zhongping Capital, Shanghai Healthcare Capital, Shenzhen Dingxin Capital Management, Fosunhealth, and NNFE.